CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- Open-market buys, last 90 days
- $757,691
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$757,691. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-24 | Levy Adam R. Chief Executive Officer | Sale | −4,000 | $1.57 | $6K | 357,692 |
| 2025-12-22 | Levy Adam R. Chief Executive Officer | Sale | −6,000 | $1.61 | $10K | 361,692 |
| 2025-11-06 | Levy Adam R. Chief Executive Officer | Sale 10b5-1 | −4,000 | $2.52 | $10K | 367,692 |
| 2025-10-03 | Henry Scott Robert Director | Sale 10b5-1 | −7,175 | $2.55 | $18K | 113,356 |
| 2025-10-03 | Levy Adam R. Chief Executive Officer | Sale 10b5-1 | −2,400 | $2.55 | $6K | 371,692 |
| 2025-10-02 | Henry Scott Robert Director | Sale 10b5-1 | −825 | $2.50 | $2K | 120,531 |
| 2025-10-02 | Levy Adam R. Chief Executive Officer | Sale 10b5-1 | −1,600 | $2.50 | $4K | 374,092 |
| 2025-09-25 | Henry Scott Robert Director | Sale 10b5-1 | −7,697 | $2.36 | $18K | 121,356 |
| 2025-08-28 | Levy Adam R. Chief Executive Officer | Sale | −4,000 | $2.47 | $10K | 358,284 |
| 2025-06-25 | glassman steven mark Director | Grant or award · Stock Option(Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-25 | glassman steven mark Director | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2025-06-25 | Henry Scott Robert Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-25 | Henry Scott Robert Director | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2025-06-25 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-25 | Stein John Nachum Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-13 | Henry Scott Robert Director | Sale 10b5-1 | −3,000 | $2.57 | $8K | 129,053 |
| 2025-06-11 | Levy Adam R. Chief Executive Officer | Sale | −2,000 | $2.39 | $5K | 362,284 |
| 2025-06-09 | Levy Adam R. Chief Executive Officer | Sale | −2,000 | $2.33 | $5K | 364,284 |
| 2025-06-05 | Levy Adam R. Chief Executive Officer | Sale | −1,000 | $2.32 | $2K | 366,284 |
| 2025-06-04 | Levy Adam R. Chief Executive Officer | Sale | −1,000 | $2.29 | $2K | 367,284 |
Page 3 of 9 · 176 trades